Novel Biomarkers Predict Heart, Kidney Disease in People with T2D
American Heart Association
The CREDENCE trial demonstrated how canagliflozin treatment brought down the levels of cardiorenal blood biomarkers
The CREDENCE trial demonstrated how canagliflozin treatment brought down the levels of cardiorenal blood biomarkers
Women’s health demands attention and intervention—more than ever before—to better understand the impact of various stressors